INF‐λ and TNF‐α levels were higher, as was nitric oxide production, in AD patients in mild and severe stages compared with patients in earlier phases (moderate stage and mild cognitive impairment), indicating progressive increases in INF‐λ and TNF‐α in human AD patients (Belkhelfa et al., 2014). This evidence concerns the gene TNF and Alzheimer disease.